Atlas Trials

Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).

Clinical trial NCT01734265 · COMPLETED

Trial details

NCT number
NCT01734265
Sponsor
Laboratorios Leti, S.L.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
AllergyRhinitisRhinoconjunctivitisSeasonal Asthma
Start date
2012-11-01
Primary completion
2013-03-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.